Pembrolizumab for Locally Advanced and Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab for Locally Advanced and Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (KEYNOTE-629 Study): An Open-Label, Nonrandomized, Multicenter, Phase 2 Trial
Ann. Oncol 2021 Jul 19;[EPub Ahead of Print], BGM Hughes, E Munoz-Couselo, L Mortier, Å Bratland, R Gutzmer, O Roshdy, RG Mendoza, J Schachter, A Arance, F Grange, N Meyer, A Joshi, S Billan, P Zhang, B Gumuscu, RF Swaby, JJ GrobFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.